Flagship Ventures Fund IV, L.P. Current Holdings: USA Other Stocks

Flagship Ventures Fund IV, L.P. current holdings: USA Other Stocks

Flagship Ventures Fund IV, L.P. reported $0.38 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 3 positions, in its Form 13F for the quarter ended 2016-03-31; the largest are Seres Therapeutics Inc., T2 Biosystems, Inc., Eleven Biotherapeutics, Inc..

• Seres Therapeutics Inc.: Country of operation United States; Class COM; Shares 14,083,579; Value $374,060,000.
• T2 Biosystems, Inc.: Country of operation —; Class COM; Shares 741,755; Value $7,314,000.
• Eleven Biotherapeutics, Inc.: Country of operation —; Class COM; Shares 1,466,417; Value $469,000.